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■Case Report■
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Extracorporeal membrane oxygenation (ECMO) is a means for supporting adequate gas exchange in patients with severe respiratory 
failure and is the only therapeutic option for ventilation-refractory patients awaiting lung transplantation. Moreover, defining the pa-
tients likely to benefit from ECMO as a bridge to transplantation has recently become a point of interest. Here, we report a case of pro-
longed ECMO support to a patient awaiting lung transplantation. A 66-year-old woman was diagnosed with acute interstitial pneumonia 
and was placed on veno-venous (VV) ECMO due to unsatisfactory gas exchange despite maximal ventilator care. She underwent bi-
lateral lung transplantation after 99 days of ECMO and was successfully weaned from it on the 107th ECMO day. This is the longest pe-
riod of ECMO support to be reported among elderly patients. 
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Extracorporeal membrane oxygenation (ECMO) is the only 
therapeutic method for patients with end stage pulmonary dis-
ease and for those waiting for lung transplantation. Due to neg-
ative outcomes reported by previous studies, ECMO has been 
considered to be a contraindication for patients waiting for fu-
ture lung transplantation.[1,2] However, developments in tech-
niques and devices have not only enabled patients to benefit 
from ECMO, but also have led to decreases in the risk of bleed-
ing and lung injury from prolonged mechanical ventilation.[3] 
Accordingly, the role of ECMO as a bridge to lung transplantation 
has garnered greater interest in the field of transplantation, espe-
cially for ventilation-refractory patients.[4,5] Several studies 
have reported on ECMO as a bridge to lung transplantation, yet 
most of them deal with relatively young patients of less than 50 
years old.[6] Herein, we report our experience of 107 days of 
ECMO as a bridge to lung transplantation in an elderly patient 
with acute interstitial pneumonia. 
CASE REPORT
A 66-year-old woman, who presented with 40 days of dyspnea, 
cough, and sputum, was diagnosed with acute interstitial pneumonia. 
She had previous medical history of hypertension and fatty liver 
disease. She was admitted to the intensive care unit and began re-
ceiving mechanical ventilation (Fig. 1a). Conventional ventilator 
techniques were applied in an effort to prevent severe hypoxia 
and inefficient gas exchange. She was placed on veno-venous 
(VV) ECMO: the use of ECMO partially corrected the abnormal 
gas status. Despite such improvements, she could not be weaned 
from ECMO, and her condition still was not stabilized (Fig. 1b). 
Therefore, lung transplantation became her only therapeutic 
option. After 105 days on the ventilator, or 99 days of ECMO 
support, she underwent bilateral lung transplantation (Fig. 2). 
She was changed to veno-arterial (VA) ECMO prior to surgery 
in case of unexpected hemodynamic instability caused by surgi-
cal manipulation. This was maintained until postoperative day 1 
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Fig. 1. Chest radiography 
at (A) 40 days after onset 
of symptoms prior to in-
tubation; (B) Progression 
of patchy opacity in both 
lungs on day 1 of ECMO; 
(C) Improved right pneu-
monic consolidation, but 
still noted haziness on left 
lung due to hematoma on 
postoperative day 4 of bi-
lateral lung transplantation;
(D) Resolution of bilateral 
consolidation on day 14 of 
surgery. 
Fig. 2. Timeline of major 
clinical events. 
when she underwent bleeder ligation and hematoma removal 
due to arterial bleeding in her chest cavity. The operation was 
uneventful and she tolerated well with the veno-venous (VV) 
ECMO. On postoperative day 4, she underwent evacuation of 
hematoma in her thoracic cavity (Fig. 1c).
Complications during the 107 days of ECMO included spon-
taneous abdominal wall hematoma on the 7th day of ECMO, 
probably due to the use of heparin. Heparinization was stopped 
on postoperative day 4 due to concern about bleeding risk and 
hematoma formation on her chest. The patient was weaned from 
the ECMO on the postoperative day 8. During the 107 days of 
ECMO support, four oxygenators were replaced. Pathologic ex-
amination showed interstitial fibrosis with fibrinous exudates. 
The postoperative course was complicated by possible pulmo-
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nary infections, sepsis, and profound critical illness myopathy, 
leading to delayed weaning from the ventilator despite proper 
rehabilitation and physical therapy. Other complications in-
cluded newly applied hemodialysis due to decreased renal func-
tion, and pressure-sores along coccyx area due to prolonged 
immobilization. She is still undergoing respiratory rehabilitation 
and is working to be weaned from the ventilator (Fig. 1d).
DISCUSSION
Although there have been many efforts to resolve organ short-
ages, finding a suitable donor is difficult, especially for those 
needing a lung transplantation. While new surgical techniques, 
such as lobar lung transplantation, are being introduced,[7] scar-
city of available donor organs reflects an imbalance in supply 
and demand. Such shortages of donor lungs have necessitated 
the introduction of ECMO as a bridge to lung transplantation for 
end stage pulmonary disease patients.
 ECMO has been widely adopted for patients with respiratory 
failure to assist adequate gas exchange. Nowadays, many physi-
cians focus on ECMO not only as a gas exchanger, but also as a 
bridge to lung transplantation. In patients with chronic respira-
tory failure and limitations in gas exchange, despite mechanical 
ventilation aid, lung transplantation could be the only available 
treatment measure. However, ECMO had been regarded as a 
contraindication for lung transplantation due to a multivariate 
risk analysis conducted by the United Network for Organ Sharing 
(UNOS), which indicated both mechanical ventilation and ECMO 
before lung transplantation as strong predictors of death.[2] The 
role of ECMO as a bridge to lung transplantation has recently 
came into the spotlight due to advancements in ECMO systems.[8] 
Previously, the longest period reported to be supported by 
ECMO was 57 days,[9] while recent studies with advanced 
ECMO systems have reported 107 and 110 days.[10,11] One 
case ended the support followed by lung transplantation, while 
the other ended upon recuperation from the disease. Our report 
describes a 66-year old woman with acute interstitial pneumonia 
who had been on ECMO due to inadequate gas exchange with 
mechanical ventilation, and had received lung transplantation. 
The patient could not be weaned off immediately after surgery 
despite bilateral lung transplantation, but was off ECMO sup-
port by postoperative day 8. Although the patient could not be 
weaned off at once after the operation and remained on ven-
tilator support, our case is of importance because the main-
tenance of ECMO support was the longest reported among eld-
erly patients. 
Despite adequate respiratory support by ECMO, many patients 
undergoing lung transplantation, especially elderly patients, face 
many other clinical issues. Adequate muscle strength is needed 
not only for successful postoperative rehabilitation and ventilator 
weaning, but also for overcoming acquired neuromuscular dis-
orders, such as critical illness myopathy, which are common among 
patients receiving prolonged mechanical ventilation.[12,13] Elderly 
patients may also already have deteriorated physical conditions 
preoperatively. Bleeding tendency due to the use of heparin for 
operating ECMO and decreased renal function are other clinical 
issues that warrant concern in patients on prolonged ECMO. 
Although our patient is still on mechanical ventilation, we 
found our experience to be worthy of reporting not only for ac-
cepting ECMO as a bridge to lung transplantation, but also for 
determining patients in whom to apply ECMO. The role of 
ECMO as a bridge to lung transplantation has already been ac-
knowledged by many physicians. Nevertheless, due to conflict-
ing results regarding to patient outcomes with ECMO, many 
study groups now focus on specifying which patients can be ex-
pected to benefit from ECMO as a bridge.[13]
In conclusion, we reported our educational experience with 
lung transplantation in a patient supported by a prolonged peri-
od of ECMO, the longest so far among elderly patients. We be-
lieve our experience can help supplement future clinical deci-
sions in determining which patients may benefit from ECMO. 
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